Abstract
Transferring genetic molecules into the peripheral sensory nervous system to manipulate nociceptive pathophysiology is a powerful approach for experimental modulation of sensory signaling and potentially for translation into therapy for chronic pain. This can be efficiently achieved by the use of recombinant adeno-associated virus (rAAV) in conjunction with nociceptor-specific regulatory transgene cassettes. Among different routes of delivery, direct injection into the dorsal root ganglia (DRGs) offers the most efficient AAV-mediated gene transfer selectively into the peripheral sensory nervous system. Here, we briefly discuss the advantages and applications of intraganglionic microinjection, and then provide a detailed approach for DRG injection, including a list of the necessary materials and description of a method for performing DRG microinjection experiments. We also discuss our experience with several adeno-associated virus (AAV) options for in vivo transgene expression in DRG neurons.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Beutler AS (2010) AAV provides an alternative for gene therapy of the peripheral sensory nervous system. Mol Ther 18(4):670–673. doi:10.1038/mt.2010.41
Glorioso JC, Fink DJ (2009) Gene therapy for pain: introduction to the special issue. Gene Ther 16(4):453–454. doi:10.1038/gt.2009.18
Goins WF, Cohen JB, Glorioso JC (2012) Gene therapy for the treatment of chronic peripheral nervous system pain. Neurobiol Dis 48(2):255–270. doi:10.1016/j.nbd.2012.05.005
Handy CR, Krudy C, Boulis N (2011) Gene therapy: a potential approach for cancer pain. Pain Res Treat 2011:987597
Fischer G, Kostic S, Nakai H, Park F, Sapunar D, Yu H, Hogan Q (2011) Direct injection into the dorsal root ganglion: technical, behavioral, and histological observations. J Neurosci Methods 199(1):43–55
Fischer G, Pan B, Vilceanu D, Hogan QH, Yu H (2013) Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion. Gene Ther. doi:10.1038/gt.2013.56
Yu H, Fischer G, Ferhatovic L, Fan F, Light AR, Weihrauch D, Sapunar D, Nakai H, Park F, Hogan QH (2013) Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats. PLoS One 8(4):e61266. doi:10.1371/journal.pone.0061266
Sloane EM, Soderquist RG, Maier SF, Mahoney MJ, Watkins LR, Milligan ED (2009) Long-term control of neuropathic pain in a non-viral gene therapy paradigm. Gene Ther 16(4):470–475. doi:10.1038/gt.2009.21
Beutler AS, Reinhardt M (2009) AAV for pain: steps towards clinical translation. Gene Ther 16(4):461–469
Eaton MJ, Blits B, Ruitenberg MJ, Verhaagen J, Oudega M (2002) Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther 9(20):1387–1395
Towne C, Pertin M, Beggah AT, Aebischer P, Decosterd I (2009) Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery. Mol Pain 5:52
Mason MR, Ehlert EM, Eggers R, Pool CW, Hermening S, Huseinovic A, Timmermans E, Blits B, Verhaagen J (2010) Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol Ther 18(4):715–724
Beutler AS, Banck MS, Walsh CE, Milligan ED (2005) Intrathecal gene transfer by adeno-associated virus for pain. Curr Opin Mol Ther 7(5):431–439
Wang X, Wang C, Zeng J, Xu X, Hwang PY, Yee WC, Ng YK, Wang S (2005) Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves. Mol Ther 12(2):314–320. doi:10.1016/j.ymthe.2005.03.032
Vulchanova L, Schuster DJ, Belur LR, Riedl MS, Podetz-Pedersen KM, Kitto KF, Wilcox GL, McIvor RS, Fairbanks CA (2010) Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Mol Pain 6:31
Storek B, Reinhardt M, Wang C, Janssen WG, Harder NM, Banck MS, Morrison JH, Beutler AS (2008) Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain. Proc Natl Acad Sci U S A 105(3):1055–1060. doi:10.1073/pnas.0708003105
Glatzel M, Flechsig E, Navarro B, Klein MA, Paterna JC, Bueler H, Aguzzi A (2000) Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci U S A 97(1):442–447
Xu Y, Gu Y, Wu P, Li GW, Huang LY (2003) Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum Gene Ther 14(9):897–906. doi:10.1089/104303403765701187
Puljak L, Kojundzic SL, Hogan QH, Sapunar D (2009) Targeted delivery of pharmacological agents into rat dorsal root ganglion. J Neurosci Methods 177(2):397–402. doi:10.1016/j.jneumeth.2008.10.029
Zhao X, Tang Z, Zhang H, Atianjoh FE, Zhao JY, Liang L, Wang W, Guan X, Kao SC, Tiwari V, Gao YJ, Hoffman PN, Cui H, Li M, Dong X, Tao YX (2013) A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci 16(8):1024–1031. doi:10.1038/nn.3438
Samad OA, Tan AM, Cheng X, Foster E, Dib-Hajj SD, Waxman SG (2012) Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain. Mol Ther. doi:10.1038/mt.2012.169
Fagoe ND, Eggers R, Verhaagen J, Mason MR (2013) A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons. Gene Ther. doi:10.1038/gt.2013.71
Federici T, Taub JS, Baum GR, Gray SJ, Grieger JC, Matthews KA, Handy CR, Passini MA, Samulski RJ, Boulis NM (2012) Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther 19(8):852–859. doi:10.1038/gt.2011.130
Lu YY, Wang LJ, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Matsushita T, Hanazono Y, Kume A, Nagatsu T, Ozawa K, Nakano I (2003) Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport. Neurosci Res 45(1):33–40
Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL (2003) Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiol Dis 14(3):535–541
Zheng H, Qiao C, Wang CH, Li J, Yuan Z, Zhang C, Xiao X (2010) Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle. Hum Gene Ther 21(1):87–97. doi:10.1089/hum.2009.131
Machida A, Kuwahara H, Mayra A, Kubodera T, Hirai T, Sunaga F, Tajiri M, Hirai Y, Shimada T, Mizusawa H, Yokota T (2013) Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice. Mol Pain 9:36. doi:10.1186/1744-8069-9-36
Acknowledgement
This work was supported by grants from the Department of Veterans Affairs Rehabilitation Research and Development (3690-03), the Advancing a Healthier Wisconsin (FP00005706), and the National Institute of Neurological Disorders and Stroke (R01NS079626-01), to Q.H.H.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Yu, H., Fischer, G., Hogan, Q.H. (2016). AAV-Mediated Gene Transfer to Dorsal Root Ganglion. In: Manfredsson, F. (eds) Gene Therapy for Neurological Disorders. Methods in Molecular Biology, vol 1382. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3271-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3271-9_18
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3270-2
Online ISBN: 978-1-4939-3271-9
eBook Packages: Springer Protocols